Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

NCT00216671 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: early initiation of treatment with Risperdal Consta
DRUG: routine initiation of treatment with Risperdal Consta

Sponsor

Janssen Pharmaceutica N.V., Belgium